Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 
 

Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology

  • Joint development and commercialization of  Merck KGaA, Darmstadt, Germany’s anti-PD-L1
  • Further maximize the potential of Merck KGaA, Darmstadt, Germany's asset in the highly competitive anti-PD-1 / anti-PD-L1 space
  • Up to 20 high priority immuno-oncology clinical development programs expected to commence in 2015, including pivotal registration studies
  • Alliance accelerates Merck KGaA, Darmstadt, Germany’s entry into the US oncology market
 

Global Strategic Alliance with Pfizer

On this site we have compiled all information including relevant links regarding our annoncement. You will find the press release, media presentation, an interview, a recording of our conference calls and photo material here.

Please Read Disclaimer
Certain statements or communications made herein relating to the proposed acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany may be deemed to be solicitation material. For more information, please click here

PRESS KIT

Press Kit
Documents for journalists and media representatives (press release, booklets, photos)

CONFERENCE CALLS

Conference Calls
You will find a recording of the conference calls here.

CONTACT

Gangolf Schrimpf
Gangolf Schrimpf
Tel: +49 6151 72 9591
Fax: +49 6151 72-919591
E-Mail

Additional information

BELÉN GARIJO

Belén Garijo
Belén Garijo in an interview.

BACKGROUND INFORMATION

Background information on our Anti-PD-L1 compound can be found here.
Background information on our Anti-PD-L1 compound can be found here.

A STRATEGIC ALLIANCE

A strategic alliance
A strategic alliance to leverage our iOnc R&D platform

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.